Buy Fortis Healthcare: IIFL Securities's Target Price Rs 545

IIFL Securities has issued a buy recommendation for Fortis Healthcare, setting a target price of Rs 545. This represents a potential upside of approximately 2.64%, as the stock is currently trading at Rs 530.95. The brokerage firm believes that investors should capitalize on this opportunity and purchase shares of Fortis Healthcare for potential gains.

About Fortis Healthcare:

Fortis Healthcare Limited, listed on the National Stock Exchange (NSE) of India, is a leading healthcare provider in India. The company operates primarily in the hospital industry, offering a range of healthcare services across multiple specialties, including cardiology, neurology, oncology, nephrology, and orthopedics. With a network of over 35 hospitals and healthcare facilities across India, Fortis Healthcare serves a diverse patient population and offers specialized treatments and procedures. The company is known for its commitment to providing quality healthcare services, supported by advanced technology and a team of skilled medical professionals.

52 Week Price Trend:

Fortis Healthcare (FORITIS) is currently trading at Rs 530.95, showing a notable rise from its 52-week low of Rs 245.4. This surge represents a significant gain of over 116%. While the stock has not yet reached its 52-week high of Rs 469.7, the current price action indicates a bullish trend. Investors may consider monitoring the stock's performance and studying the underlying fundamentals to evaluate its potential for further growth.

Stratzy's MOST Analysis:

Fortis has received a "BB" rating by Stratzy's MOST framework. This rating is based on the company's performance in the areas of management, outlook, safety, and trend. Fortis has received a score of "B" in the management pillar, indicating that it has a strong management team with a good track record. In the outlook pillar, Fortis has received a score of "B", which indicates that the company has a positive outlook for the future. In the safety pillar, Fortis has received a score of "B", indicating that it has a strong financial position and is not at risk of default. In the trend pillar, Fortis has received a score of "B", indicating that the company is performing well and is expected to continue to do so in the future. Overall, Fortis has received a "BB" rating, indicating that it has medium fundamental risks.

Company's Fundamentals:

Fortis Healthcare (NSE: FORTIS) is a company listed on the National Stock Exchange of India. The company's stock has a Price to Earnings (PE) ratio of 60.64, which means that investors are willing to pay Rs. 60.64 for every Re. 1 of earnings. The Price to Book (PB) ratio of 4.27 indicates that investors are willing to pay Rs. 4.27 for every Re. 1 of book value. The dividend yield of 0.23% means that investors will receive Rs. 0.23 for every Rs. 100 invested in the stock.

Fundamental and Technical information provided in this blog were last updated on 13 Aug, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.